474
Views
12
CrossRef citations to date
0
Altmetric
Reviews

The Effect of Resveratrol on Cellular Senescence in Normal and Cancer Cells: Focusing on Cancer and Age-Related Diseases

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1175-1180 | Received 12 Oct 2018, Accepted 22 Feb 2019, Published online: 07 Apr 2019

References

  • Campisi J and d'Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8, 729–740, 2007.
  • Campisi J: Aging, cellular senescence, and cancer. Annu Rev Physiol 75, 685–705, 2013.
  • Campisi J, Andersen J, Kapahi P, and Melov S: Cellular senescence: a link between cancer and age-related degenerative disease?. Semin Cancer Biol 21, 354–359, 2011.
  • Rodier F and Campisi J: Four faces of cellular senescence. J Cell Biol 192, 547–556, 2011.
  • Burton DGA and Krizhanovsky V: Physiological and pathological consequences of cellular senescence. Cell Mol Life Sci 71, 4373–4386, 2014.
  • Campisi J: Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 11, S27–S31, 2001.
  • Dimri GP: What has senescence got to do with cancer?. Cancer Cell 7, 505–512, 2005.
  • Gewirtz DA, Holt SE, and Elmore LW: Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 76, 947–957, 2008.
  • Ewald JA, Desotelle JA, Wilding G, and Jarrard DF: Therapy-induced senescence in cancer. J Natl Cancer Inst 102, 1536–1546, 2010.
  • Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, et al.: A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335–346, 2002.
  • Amiri F, Zarnani A-H, Zand H, Koohdani F, Jeddi-Tehrani M, et al.: Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines. Eur J Pharmacol 718, 34–40, 2013.
  • Kirkland JL: Perspectives on cellular senescence and short term dietary restriction in adults. Aging 2, 894–896, 2010.
  • Gao Z, Xu MS, Barnett TL, and Xu CW: Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells. Biochem Biophys Res Commun 407, 271–276, 2011.
  • Harikumar KB and Aggarwal BB: Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7, 1020–1035, 2008.
  • Ghorbani A, Zand H, Jeddi-Tehrani M, Koohdani F, Shidfar F, et al.: PTEN over-expression by resveratrol in acute lymphoblastic leukemia cells along with suppression of AKT/PKB and ERK1/2 in genotoxic stress. J Nat Med 69, 507–512, 2015.
  • Saiko P, Szakmary A, Jaeger W, and Szekeres T: Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 658, 68–94, 2008.
  • Li B, Hou D, Guo H, Zhou H, Zhang S, et al.: Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells. Scientific Reports 7, 208, 2017.
  • Bishayee A and Dhir N: Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem Biol Interact 179, 131–144, 2009.
  • Athar M, Back J, Tang X, Kim K, Kopelovich L, et al.: Resveratrol: a review of pre-clinical studies for human cancer prevention. Toxicol Appl Pharmacol 224, 274–283, 2007.
  • Yang Q, Wang B, Zang W, Wang X, Liu Z, et al.: Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One 8, e70627, 2013.
  • Luo H, Yang A, Schulte BA, Wargovich MJ, Wang GY, et al.: Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. PLoS One 8, e60065, 2013.
  • Li P, Xu J, Wu X, Guo Z, Fan L, et al.: Resveratrol attenuates high glucose-induced nucleus pulposus cell apoptosis and senescence through activating the ROS-mediated PI3K/Akt pathway. Biosci Rep 38, 2017.
  • Zhang N, Li Z, Xu K, Wang Y, Wang Z, et al.: Resveratrol protects against high-fat diet induced renal pathological damage and cell senescence by activating SIRT1. Biol Pharm Bull 39, 1448–1454, 2016.
  • Zhang E, Guo Q, Gao H, Xu R, Teng S, et al.: Metformin and resveratrol inhibited high glucose-induced metabolic memory of endothelial senescence through SIRT1/p300/p53/p21 pathway. PLoS One 10, e0143814, 2015.
  • Tang Y, Xu J, Qu W, Peng X, Xin P, et al.: Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms. J Nutr Biochem 23, 1410–1416, 2012.
  • Te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP, et al.: DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62, 1876–1883, 2002.
  • Bennecke M, Kriegl L, Bajbouj M, Retzlaff K, Robine S, et al.: Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell 18, 135–146, 2010.
  • Joe AK, Liu H, Suzui M, Vural ME, Xiao D, et al.: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8, 893–903, 2002.
  • Hussain AR, Uddin S, Bu R, Khan OS, Ahmed SO, et al.: Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines. PLoS One 6, e24703, 2011.
  • Velioglu-Ogunc A, Sehirli O, Toklu HZ, et al. Resveratrol protects against irradiation-induced hepatic and ileal damage via its anti-oxidative activity. Free Radic Res 43, 1060–1071, 2009.
  • Fang Y, DeMarco VG, and Nicholl MB: Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci 103, 1090–1098, 2012.
  • Zamin LL, Filippi-Chiela EC, Dillenburg-Pilla P, Horn F, Salbego C, et al.: Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci 100, 1655–1662, 2009.
  • Heiss EH, Schilder YD, and Dirsch VM: Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells. J Biol Chem 282, 26759–26766, 2007.
  • Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al.: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24, 2783–2840, 2004.
  • Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, et al.: Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105, 1541–1544, 2002.
  • Shen X, Wang M, Bi X, Zhang J, Wen S, et al.: Resveratrol prevents endothelial progenitor cells from senescence and reduces the oxidative reaction via PPARgamma/HO1 pathways. Oxid Med Cell Longev 14, 5528–5534, 2016.
  • Xu D, Neville R, and Finkel T: Homocysteine accelerates endothelial cell senescence. FEBS Lett 470, 20–24, 2000.
  • Xia L, Wang XX, Hu XS, Guo XG, Shang YP, et al.: Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br J Pharmacol 155, 387–394, 2009.
  • Wang XB, Zhu L, Huang J, Yin YG, Kong XQ, et al.: Resveratrol-induced augmentation of telomerase activity delays senescence of endothelial progenitor cells. Chin Med J (Engl) 124, 4310–4315, 2011.
  • Kao C-L, Chen L-K, Chang Y-L, Yung M-C, Hsu C-C, et al.: Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. JAT 17, 970–979, 2010.
  • Scalera F, Borlak J, Beckmann B, Martens-Lobenhoffer J, Thum T, et al.: Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. ATVB 24, 1816–1822, 2004.
  • Konishi H, Sydow K, and Cooke JP: Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury. J Am Coll Cardiol 49, 1099–1105, 2007.
  • Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, et al.: Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106, 987–992, 2002.
  • Yuan Q, Peng J, Liu S-Y, Wang C-J, Xiang D-X, et al.: Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway. Clin Exp Pharmacol Physiol 37, 630–635, 2010.
  • Ota H, Akishita M, Tani H, Tatefuji T, Ogawa S, et al.: trans-Resveratrol in Gnetum gnemon protects against oxidative-stress-induced endothelial senescence. J Nat Prod 76, 1242–1247, 2013.
  • Matos L, Gouveia AM, and Almeida H: Resveratrol attenuates copper-induced senescence by improving cellular proteostasis. Oxid Med Cell Longev 2017, 3793817, 2017.
  • Kilic Eren M, Kilincli A, and Eren Ö: Resveratrol induced premature senescence is associated with DNA Damage Mediated SIRT1 and SIRT2 down-regulation. PLoS One 10, e0124837, 2015.
  • Giovannelli L, Pitozzi V, Jacomelli M, Mulinacci N, Laurenzana A, et al.: Protective effects of resveratrol against senescence-associated changes in cultured human fibroblasts. J Gerontol A Biol Sci Med Sci 66, 9–18, 2011.
  • Faragher RGA, Burton DGA, Majecha P, Fong NSY, Davis T, et al.: Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts. Age (Dordr) 33, 555–564, 2011.
  • Shiozaki M, Hayakawa N, Shibata M, Koike M, Uchiyama Y, et al.: Closer association of mitochondria with lipid droplets in hepatocytes and activation of Kupffer cells in resveratrol-treated senescence-accelerated mice. Histochem Cell Biol 136, 475–489, 2011.
  • Cristofol R, Porquet D, Corpas R, Coto-Montes A, Serret J, et al.: Neurons from senescence-accelerated SAMP8 mice are protected against frailty by the sirtuin 1 promoting agents melatonin and resveratrol. J Pineal Res 52, 271–281, 2012.
  • Liu G-S, Zhang Z-S, Yang B, and He W: Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice. Life Sci 91, 872–877, 2012.
  • Ichiki T, Miyazaki R, Kamiharaguchi A, Hashimoto T, Matsuura H, et al.: Resveratrol attenuates angiotensin II-induced senescence of vascular smooth muscle cells. Regul Pept 177, 35–39, 2012.
  • Jeyapalan JC and Sedivy JM: Cellular senescence and organismal aging. Mech Ageing Dev 129, 467–474, 2008.
  • Ido Y, Duranton A, Lan F, Weikel KA, Breton L, et al.: Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes. PLoS One 10, e0115341, 2015.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.